Study Site 16018 — Rapid City, South Dakota

Study Site 16018 is a clinical research site located in Rapid City, South Dakota, United States 57701.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Study Site 16018 has participated in 2 clinical trials.

Therapeutic areas: Acute Myocardial Infarction, Moderate Renal Impairment.

Sponsors: CSL Behring.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site 16018?

Study Site 16018 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site 16018 conducted?

Study Site 16018 has 2 clinical trials on record. Their work covers Acute Myocardial Infarction, Moderate Renal Impairment.

Is Study Site 16018 accredited by Crixeo Health?

Study Site 16018 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site 16018?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.